Literature DB >> 15708932

Psoriasis pathophysiology: current concepts of pathogenesis.

J G Krueger1, A Bowcock.   

Abstract

Psoriasis vulgaris is a common skin disorder characterised by focal formation of inflamed, raised plaques that constantly shed scales derived from excessive growth of skin epithelial cells. The disease is defined by a series of linked cellular changes in the skin: hyperplasia of epidermal keratinocytes, vascular hyperplasia and ectasia, and infiltration of T lymphocytes, neutrophils, and other types of leucocyte in affected skin. In a relatively short period, psoriasis vulgaris has been conceptualised as a T lymphocyte mediated autoimmune disease and new biological therapies that target T cells have just entered routine clinical practice. Similarly, rapid progress has been made towards dissecting cellular and molecular pathways of inflammation that contribute to disease pathogenesis. This short review presents current pathogenic concepts that have emerged from genetic, genomic, and cellular information obtained in basic studies and from clinical studies of selective immune targeting drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708932      PMCID: PMC1766865          DOI: 10.1136/ard.2004.031120

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  52 in total

1.  Positional identification of Ncf1 as a gene that regulates arthritis severity in rats.

Authors:  Peter Olofsson; Jens Holmberg; Jesper Tordsson; Shemin Lu; Bo Akerström; Rikard Holmdahl
Journal:  Nat Genet       Date:  2002-12-02       Impact factor: 38.330

2.  Innate immune-related receptors in normal and psoriatic skin.

Authors:  Jonathan L Curry; Jian-Zhong Qin; Brian Bonish; Ryan Carrick; Patricia Bacon; Jeffrey Panella; June Robinson; Brian J Nickoloff
Journal:  Arch Pathol Lab Med       Date:  2003-02       Impact factor: 5.534

3.  Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations.

Authors:  Tomas Büchler; Roman Hajek; Lida Bourkova; Lucie Kovarova; Romana Musilova; Alena Bulikova; Michal Doubek; Adam Svobodnik; Iveta Mareschova; Pavlina Vanova; Eva Tuzova; Petra Vidlakova; Jiri Vorlicek; Miroslav Penka
Journal:  Vaccine       Date:  2003-02-14       Impact factor: 3.641

4.  A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.

Authors:  Ludmila Prokunina; Casimiro Castillejo-López; Fredrik Oberg; Iva Gunnarsson; Louise Berg; Veronica Magnusson; Anthony J Brookes; Dmitry Tentler; Helga Kristjansdóttir; Gerdur Gröndal; Anne Isine Bolstad; Elisabet Svenungsson; Ingrid Lundberg; Gunnar Sturfelt; Andreas Jönssen; Lennart Truedsson; Guadalupe Lima; Jorge Alcocer-Varela; Roland Jonsson; Ulf B Gyllensten; John B Harley; Donato Alarcón-Segovia; Kristján Steinsson; Marta E Alarcón-Riquelme
Journal:  Nat Genet       Date:  2002-10-28       Impact factor: 38.330

Review 5.  Psoriasis.

Authors:  Mark Lebwohl
Journal:  Lancet       Date:  2003-04-05       Impact factor: 79.321

6.  Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris.

Authors:  J B Rottman; T L Smith; K G Ganley; T Kikuchi; J G Krueger
Journal:  Lab Invest       Date:  2001-03       Impact factor: 5.662

7.  Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis.

Authors:  Yu-Ping Xia; Baosheng Li; Donna Hylton; Michael Detmar; George D Yancopoulos; John S Rudge
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

8.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.

Authors:  Xianghong Zhou; James G Krueger; Ming-Chih J Kao; Ed Lee; Fenghe Du; Alan Menter; Wing Hung Wong; Anne M Bowcock
Journal:  Physiol Genomics       Date:  2003-03-18       Impact factor: 3.107

9.  Infliximab monotherapy provides rapid and sustained benefit for plaque-type psoriasis.

Authors:  Alice B Gottlieb; Umesh Chaudhari; Lisa D Mulcahy; Shu Li; Lisa T Dooley; Daniel G Baker
Journal:  J Am Acad Dermatol       Date:  2003-06       Impact factor: 11.527

10.  IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14/p40 transgenic mice: evidence for enhanced cutaneous immunity.

Authors:  Tamara Kopp; Petra Lenz; Concha Bello-Fernandez; Robert A Kastelein; Thomas S Kupper; Georg Stingl
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

View more
  85 in total

Review 1.  Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology.

Authors:  Philip Mease
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

2.  A medical conundrum: onset of psoriasis in patients receiving anti-tumour necrosis factor agents.

Authors:  C Ritchlin; F Tausk
Journal:  Ann Rheum Dis       Date:  2006-12       Impact factor: 19.103

Review 3.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

4.  Celiac sprue: a unique autoimmune disorder.

Authors:  Shadi Rashtak; Eric V Marietta; Joseph A Murray
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

Review 5.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

6.  Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine.

Authors:  Spyros Aslanidis; Athina Pyrpasopoulou; Stella Douma; Areti Triantafyllou
Journal:  Clin Rheumatol       Date:  2007-11-10       Impact factor: 2.980

Review 7.  MicroRNAs in normal and psoriatic skin.

Authors:  Jing Xia; Weixiong Zhang
Journal:  Physiol Genomics       Date:  2013-12-10       Impact factor: 3.107

8.  Assessment of the Therapeutic Aspect of Systemic Non-Biologic Anti-Psoriatic Treatment Modalities Used in Combination with Methotrexate.

Authors:  Kamran Balighi; Ghodsi Seyedeh Zahra; Goodarzi Azadeh; Hejazi Pardis; Sepehri Ehsan; Azizpour Arghavan
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

9.  Activation of keratinocyte protein kinase C zeta in psoriasis plaques.

Authors:  Yuming Zhao; Rita Fishelevich; John P Petrali; Lida Zheng; Malinina Alla Anatolievna; April Deng; Richard L Eckert; Anthony A Gaspari
Journal:  J Invest Dermatol       Date:  2008-04-03       Impact factor: 8.551

Review 10.  New insights into the pathogenesis and genetics of psoriatic arthritis.

Authors:  Kristine E Nograles; Richard D Brasington; Anne M Bowcock
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.